Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 29, 2015 8:18 PM ET

Capital Markets

Company Overview of 5AM Venture Management LLC

Company Overview

5AM Ventures is a venture capital firm specializing in seed, early-stage, startup investments, and spinouts. The firm prefers to invest in life science companies with a focus on drug development, biotechnology, product discovery platforms, and medical technologies. In drug development, it focuses on companies discovering and developing drugs focused on specific therapeutic areas such as anti-infectives, diabetes, metabolic diseases, and oncology. Within medical technologies, the firm focuses on areas such as drug delivery, diagnostics, imaging agents, materials science, and medical devices. It prefers to be the lead investor and make equity investments. It seeks to take a board seat of the m...

2200 Sand Hill Road

Suite 110

Menlo Park, CA 94025

United States

Founded in 2002





Key Executives for 5AM Venture Management LLC

Managing Partner and Founder
Age: 71
Co-Founder and Managing Partner
Age: 43
Chief Financial Officer
General Counsel and Chief Operating Officer
Managing Partner
Age: 60
Compensation as of Fiscal Year 2014.

5AM Venture Management LLC Key Developments

5AM Venture Management LLC Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

5AM Venture Management LLC Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

5AM Venture Management LLC Announces Executive Appointments

5AM Venture Management LLC announced the addition of Brian F. Daniels, M.D. as a Venture Partner and Stephen J. Bonelli, C.P.A. as Chief Financial Officer. Dr. Daniels has extensive experience in clinical development, medical affairs and corporate strategy across a broad range of therapeutic areas. He most recently was Senior Vice President, Global Development and Medical Affairs for Bristol-Myers Squibb, and a member of the Senior Management Team, the company’s most senior leadership group. Steve Bonelli recently joined 5AM from Three Arch Partners, where he was CFO from 2005-2014. Prior to Three Arch, Steve had over 20 years of experience as a financial professional, including ten years as senior financial executive in the life sciences industry. He served as CFO of U-Systems.

5AM Venture Management LLC Presents at 12th Annual BIO Investor Forum, Oct-09-2013 03:30 PM

5AM Venture Management LLC Presents at 12th Annual BIO Investor Forum, Oct-09-2013 03:30 PM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
American Heartland Sagebrush Securities Investments, Inc. United States
Cabrillo Advisors, LLC United States
Amhearst Glen, Inc. United States
Medley Advisory, LLC United States
GE Funding Capital Market Services, Inc. United States

Recent Private Companies Transactions

Private Placement
March 10, 2015
Pear Therapeutics Inc.
Private Placement
November 21, 2014
Audentes Therapeutics, Inc.
Private Placement
May 30, 2014
Chrono Therapeutics Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 5AM Venture Management LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at